(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
3 days till quarter result
(bmo 2024-04-30)
Expected move: +/- 3.43%
0.66% $ 33.81
@ $38.14
Выпущен: 14 февр. 2024 @ 17:30
Доходность: -11.35%
Предыдущий сигнал: февр. 13 - 17:30
Предыдущий сигнал:
Доходность: -0.52 %
Live Chart Being Loaded With Signals
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada...
Stats | |
---|---|
Объем за сегодня | 37 445.00 |
Средний объем | 61 225.00 |
Рыночная капитализация | 806.52M |
EPS | $0 ( 2024-02-13 ) |
Дата следующего отчета о доходах | ( $0 ) 2024-04-30 |
Last Dividend | $0.120 ( 2023-12-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.05 |
ATR14 | $0.0470 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Stacy Linda | Buy | 0 | |
2024-03-27 | Nunnelly John N | Buy | 9 259 | Common Stock |
2024-03-27 | Nunnelly John N | Sell | 3 487 | Common Stock |
2024-03-27 | Nunnelly John N | Sell | 9 259 | Director Stock Option (Right to Buy) |
2024-03-01 | Common Property Trust | Sell | 598 653 | Common Stock |
INSIDER POWER |
---|
-90.74 |
Last 96 transactions |
Buy: 143 501 | Sell: 1 953 935 |
Объем Корреляция
National Research Corp Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
National Research Corp Корреляция - Валюта/Сырье
National Research Corp Финансовые показатели
Annual | 2023 |
Выручка: | $148.58M |
Валовая прибыль: | $86.67M (58.33 %) |
EPS: | $1.260 |
FY | 2023 |
Выручка: | $148.58M |
Валовая прибыль: | $86.67M (58.33 %) |
EPS: | $1.260 |
FY | 2022 |
Выручка: | $151.57M |
Валовая прибыль: | $94.52M (62.36 %) |
EPS: | $1.280 |
FY | 2021 |
Выручка: | $147.95M |
Валовая прибыль: | $95.60M (64.62 %) |
EPS: | $1.473 |
Financial Reports:
No articles found.
National Research Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$1.120 (N/A) |
$0.120 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0600 | 2014-12-29 |
Last Dividend | $0.120 | 2023-12-28 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-12 | |
Next Payout Date | N/A | |
# dividends | 35 | -- |
Total Paid Out | $6.34 | -- |
Avg. Dividend % Per Year | 1.58% | -- |
Score | 4.63 | -- |
Div. Sustainability Score | 8.98 | |
Div.Growth Potential Score | 5.35 | |
Div. Directional Score | 7.16 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.0600 | 0.32% |
2015 | $0.620 | 4.48% |
2016 | $0.340 | 2.23% |
2017 | $0.400 | 2.13% |
2018 | $1.130 | 3.07% |
2019 | $0.780 | 2.04% |
2020 | $0.210 | 0.32% |
2021 | $0.480 | 1.12% |
2022 | $0.840 | 1.99% |
2023 | $1.480 | 3.80% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.208 | 1.500 | 5.83 | 8.75 | [0 - 0.5] |
returnOnAssetsTTM | 0.253 | 1.200 | 1.568 | 1.882 | [0 - 0.3] |
returnOnEquityTTM | 0.478 | 1.500 | 5.80 | 8.70 | [0.1 - 1] |
payoutRatioTTM | 1.174 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 0.673 | 0.800 | -1.636 | -1.309 | [1 - 3] |
quickRatioTTM | 0.532 | 0.800 | -1.574 | -1.259 | [0.8 - 2.5] |
cashRatioTTM | 0.184 | 1.500 | -0.0902 | -0.135 | [0.2 - 2] |
debtRatioTTM | 0.305 | -1.500 | 4.92 | -7.39 | [0 - 0.6] |
interestCoverageTTM | 46.46 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.560 | 2.00 | 9.48 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.762 | -1.500 | 6.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.613 | 1.000 | 3.11 | 3.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.270 | 1.000 | 6.61 | 6.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.022 | 1.000 | 5.43 | 5.43 | [0.2 - 2] |
assetTurnoverTTM | 1.214 | 0.800 | 5.24 | 4.19 | [0.5 - 2] |
Total Score | 8.98 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.68 | 1.000 | 7.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.478 | 2.50 | 7.30 | 8.70 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.70 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.38 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.560 | 2.00 | 9.48 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.174 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -5.87 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.257 | 1.000 | 6.09 | 0 | [0.1 - 0.5] |
Total Score | 5.35 |
National Research Corp
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа